Institute of Bioengineering and Nanotechnology (IBN)

Curiox Biosystems, an A*STAR spin-off company, specializes in automated and quantitative cell analysis. Its CEO, Dr. Namyong Kim, shares the story of the company’s success.

A*STAR scientists have developed a drug delivery complex derived from green tea that enhances the safety and effectiveness of cancer treatment

A*STAR researchers have devised a method to generate a renewable source of mature human Kupffer cells for liver toxicity bioassays.

Using an expanded genetic alphabet containing fluorescent artificial DNA bases, scientists can now visually detect and quantify DNA molecules for use in diagnostics.

Cathode material made from organic molecules enhances the green credentials of rechargeable batteries

Generating large numbers of universal immune cells could transform cancer immunotherapy

Synthetic
channel with a strong preference for potassium ions offers rapid transport
through artificial membrane.

Synthetic
molecules promise to relieve debilitating eye disease

A surprising finding shows that some clusters of cells commonly found in the bloodstream of colorectal cancer patients are actually non-cancerous

Rapid synthesis of ring-shaped molecules offers a cheap route to a plethora of polymers with health and environmental applications

Powered by a proton gradient, a world-first helical molecule transports water across membranes

Flat, diamond-shaped plates of lithium iron phosphate improve discharge voltages